• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Faculty of 1000 to launch open access publishing venture

Faculty of 1000 to launch open access publishing venture

February 17, 2012
CenterWatch Staff

Faculty of 1000 (F1000) is set to launch F1000 Research, a new fully open access publishing program across biology and medicine, later this year.

The program will address the major issues afflicting scientific publishing today: timely dissemination of research, peer review and sharing of data. Diverging from traditional journal publishing, F1000 Research will offer immediate publication; open, post-publication peer review; open revisioning of work including ongoing updates; and encouragement of raw data deposition and publication.

In addition, F1000 Research will accept a broad range of article formats and will encourage content types now routinely rejected, such as negative results, case studies, thought experiments, preliminary analyses and incomplete data sets.

“The open access model has addressed effectively the issue of inadequate access to research findings,” Vitek Tracz, chairman and founder of F1000. “It did not address the major issues around communicating the research finding: the delays in access, the inadequacies of peer review and the complexities of data publishing. It is up to collaboration between researchers and publishers to come up with a solution, and we are determined to be a part of it.”

Dr. Rebecca Lawrence, who is leading the project at F1000, added, “Many questions remain as we fine tune F1000 Research to break new ground in scholarly publishing. We therefore invite those working in the bioresearch community, institutions, funders, data centers and repositories, and data mining and informatics groups to join us in open discussion and debate about these many outstanding issues—via the RSS feed or by Twitter: @F1000Research.”

F1000 was conceived in 2002 as a collaboration of 1000 international faculty members. It identifies and evaluates the most important articles in biology and medical research publications.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing